Treatment Guidelines Materials

This webpage explains Assembly Bill 2132, which mandates tuberculosis (TB) risk assessment and testing for adult primary care patients in California.

This journal discusses a case of tertiary syphilis leading to ocular syphilis and complications such as retinal detachment. It highlights the diagnostic challenges, treatment approaches, and clinical implications of late-stage syphilis affecting the eyes.

This webpage explores the treatment of Hepatitis C (HCV) and HIV coinfection, addressing the complexities of managing both infections simultaneously. It discusses antiviral treatment options, potential drug interactions, and strategies for monitoring and managing the dual conditions effectively.

This guideline provides recommendations for HIV care teams on implementing long-acting injectable HIV treatment, including cabotegravir and rilpivirine. 

This fact sheet provides a detailed comparison of tuberculosis (TB) treatment regimens, encompassing both drug-sensitive and drug-resistant TB. 

This report outlines the National Institute of Allergy and Infectious Diseases' (NIAID) updated strategic plan to combat tuberculosis. It focuses on four key priorities: enhancing fundamental knowledge of TB, advancing diagnostic research, accelerating vaccine development, and supporting strategies to treat and prevent TB.

This webpage discusses the critical role of early testing, diagnosis, and treatment in controlling the spread of tuberculosis (TB) and saving lives. It highlights local efforts to improve TB prevention and care, focusing on the impact of timely intervention on reducing TB transmission in specific communities. 

This booklet provides comprehensive information on hepatitis C, detailing its impact on liver health, modes of transmission, symptoms, and the importance of testing and treatment. The booklet outlines the progression from acute to chronic infection, potential liver complications, and available diagnostic tests. 

This journal examines the clinical course of autoimmune hepatitis (AIH) in Hispanic and African American patients at a South Bronx hospital. The findings contribute to a better understanding of AIH in diverse racial and ethnic groups, emphasizing the need for tailored healthcare strategies.

This journal evaluates the Oregon HOPE TeleHCV study, a peer-facilitated telemedicine model (Peer TeleHCV) for hepatitis C virus (HCV) treatment among people who use drugs (PWUD) in rural Oregon. The findings highlight high patient satisfaction and key factors that enhanced implementation, demonstrating the model’s potential to reduce barriers and improve treatment access.